Skip to main content
Log in

Target joints cost driver in severe haemophilia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Novo Nordisk.

  2. The study was funded by Novo Nordisk.

Reference

  • O'Hara J, et al. The relationship between target joints and direct resource use in severe haemophilia. Health Economics Review : 16 Jan 2018. Available from: URL: https://doi.org/10.1186/s13561-018-0185-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Target joints cost driver in severe haemophilia. PharmacoEcon Outcomes News 795, 31 (2018). https://doi.org/10.1007/s40274-018-4669-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4669-9

Navigation